A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. Earlier this year, Caremark revealed that it would remove Eli Lilly's blockbuster drug ...
"Class actions are no longer just a litigation threat—they're threats for which corporate boards, investors and insurers must proactively plan," Duane Morris partner Gerald Maatman said.
Tobi is a crypto writer at Investopedia. He aims to simplify the complex concepts of blockchain and cryptocurrencies for the masses. Suzanne is a content marketer, writer, and fact-checker. She holds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results